Literature DB >> 30430008

Effect of a multifaceted stewardship intervention on antibiotic prescribing and outcomes for acute bacterial skin and skin structure infections.

Danya Roshdy1, Rupal Jaffa1, Kelly E Pillinger1, Josh Guffey2, Nigel Rozario3, Lisa Davidson4, Lewis McCurdy4.   

Abstract

BACKGROUND: Acute bacterial skin and skin structure infections (ABSSSI) are a leading cause of hospitalization, but are often treated inappropriately in the inpatient setting. A multifaceted stewardship intervention was implemented to encourage prescribing of guideline-concordant therapy (GCT).
OBJECTIVE: To examine the impact of this initiative on antimicrobial prescribing practices and patient outcomes.
METHODS: This was a single-center, retrospective study of adult inpatients admitted with a primary or secondary diagnosis of ABSSSI, classified by type and severity based on signs of systemic infection. Patients treated during the pre-intervention period (pre-IP) were compared with patients treated during the post-intervention period (post-IP). The primary endpoint was receipt of GCT. Secondary endpoints included receipt of anti-anaerobic antibiotic (AAA) or broad-spectrum antibiotics (BSA).
RESULTS: A total of 125 patients were included, 64 in the pre-IP and 61 in the post-IP. There was a statistically significant increase in prescribing of GCT during the post-IP compared with the pre-IP (14% versus 56%, p < 0.0001) and a decrease in use of AAA (56% versus 34%, p = 0.01). No difference was observed with use of BSA (16% versus 15%, p = 0.89). Use of the computerized order set during the post-IP was low (18%). There was a numerical, but non-significant reduction in 30-day readmission (14.1% versus 6.6%, p = 0.17).
CONCLUSION: The multifaceted intervention was effective for improving prescribing of GCT for ABSSSI. Given low use of the computerized order set, improved prescribing seemed to be driven by provider education. Strategies around ongoing education may be key to sustain positive results of stewardship interventions.

Entities:  

Keywords:  antibiotics; bacterial infections; clinical practice guidelines; evidence-based practice; infectious diseases

Year:  2018        PMID: 30430008      PMCID: PMC6210634          DOI: 10.1177/2049936118786424

Source DB:  PubMed          Journal:  Ther Adv Infect Dis        ISSN: 2049-9361


  10 in total

1.  Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.

Authors:  Timothy C Jenkins; Allison L Sabel; Ellen E Sarcone; Connie S Price; Philip S Mehler; William J Burman
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

2.  Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.

Authors:  Mical Paul; Steen Andreassen; Evelina Tacconelli; Anders D Nielsen; Nadja Almanasreh; Uwe Frank; Roberto Cauda; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2006-09-23       Impact factor: 5.790

3.  Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system.

Authors:  M K Yong; K L Buising; A C Cheng; K A Thursky
Journal:  J Antimicrob Chemother       Date:  2010-03-09       Impact factor: 5.790

4.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Sheldon L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2014-07-15       Impact factor: 9.079

5.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-04-13       Impact factor: 9.079

6.  Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess.

Authors:  Timothy C Jenkins; Bryan C Knepper; Allison L Sabel; Ellen E Sarcone; Jeremy A Long; Jason S Haukoos; Steven J Morgan; Walter L Biffl; Andrew W Steele; Connie S Price; Philip S Mehler; William J Burman
Journal:  Arch Intern Med       Date:  2011-02-28

7.  A computer-assisted management program for antibiotics and other antiinfective agents.

Authors:  R S Evans; S L Pestotnik; D C Classen; T P Clemmer; L K Weaver; J F Orme; J F Lloyd; J P Burke
Journal:  N Engl J Med       Date:  1998-01-22       Impact factor: 91.245

8.  Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections.

Authors:  Timothy R Pasquale; Tamara L Trienski; Deanna E Olexia; Deana E Olexia; Joseph P Myers; Michael J Tan; Anthony K Leung; Jose E Poblete; Thomas M File
Journal:  Am J Health Syst Pharm       Date:  2014-07-01       Impact factor: 2.637

Review 9.  Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines.

Authors:  Gregory J Moran; Fredrick M Abrahamian; Frank Lovecchio; David A Talan
Journal:  J Emerg Med       Date:  2013-03-05       Impact factor: 1.484

10.  Improving Management of Hospitalized Adults With Uncomplicated Cellulitis or Cutaneous Abscess.

Authors:  Erica Housman; Sarah E Livings; Alex Knee; Jennifer Schimmel
Journal:  Open Forum Infect Dis       Date:  2017-06-20       Impact factor: 3.835

  10 in total
  1 in total

1.  Identifying patients with acute bacterial skin and skin structure infection who need blood cultures.

Authors:  Giusy Tiseo; Antonino Mazzone; Marco Falcone
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.